PLMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PLMR is not a good buy right now for an impatient buyer. Despite strong fundamentals and clearly bullish Wall Street positioning, the stock is in a short-to-intermediate bearish technical posture (below key averages, MACD negative) and is trading below the pivot (126.4) with near-term downside risk toward support (121). Without an Intellectia buy signal today, the higher-probability move is to avoid initiating a fresh position at 123.4 and instead treat it as a HOLD until the price shows strength back above the pivot/resistance zone.
Trend/levels: The moving average stack is bearish (SMA_200 > SMA_20 > SMA_5), indicating the stock is in a downward trend phase. Price (123.42) is below the pivot (126.422), which keeps the near-term bias negative. Key levels: Support S1=121.072 (then S2=117.767). Resistance R1=131.772 (then R2=135.077). Momentum: MACD histogram is negative (-1.202) but contracting, suggesting downside momentum is still present but may be stabilizing. RSI(6)=40.345 is weak/neutral (not oversold), so there’s room for further downside before a typical mean-reversion “forced bounce.” Tape: Pre-market is -1.39%, aligning with the bearish setup. Pattern stats (provided): Similar-pattern study implies modest upside bias over the next week (+3.58%) but with only a 40% hit-rate, which is not strong enough to override the current bearish trend.
Intellectia Proprietary Trading Signals
Strong growth profile: 2025/Q3 revenue +65.77% YoY, net income +68.72% YoY, EPS +62.61% YoY.
Wall Street momentum: Multiple recent price target increases (JPMorgan to $155; KBW to $
with Overweight/Outperform ratings.
Call-skewed options positioning (very low put/call ratios) and low IV rank/percentile (potentially supportive for upside positioning).
Upcoming event: QDEC 2025 earnings on 2026-02-17 (after hours) can act as a catalyst if results/guide beat expectations.
Technical downtrend: Bearish moving-average alignment and price below pivot (126.
suggest rallies may face selling pressure near resistance (131.8).
Near-term weakness: Pre-market down (-1.39%) and RSI not oversold increase risk of a continuation move toward 121 support.
Sector backdrop: JPMorgan notes P&C fundamentals are “getting more challenging,” implying potential headwinds (pricing/margins/growth) even if partly reflected in sentiment.
Event risk: Earnings on 2026-02-17 can produce a sharp repricing in either direction.
Latest reported quarter: 2025/Q3. Revenue grew to $241.171M (+65.77% YoY), net income rose to $51.455M (+68.72% YoY), and EPS increased to $1.87 (+62.61% YoY). Overall, the quarter shows strong top-line acceleration with even faster bottom-line/EPS growth, supporting the bull case fundamentally.
Recent trend: Analysts have been raising price targets while maintaining bullish ratings. JPMorgan (2026-01-07) raised PT to $155 (Overweight). Keefe Bruyette (2026-01-06) raised PT to $171 (Outperform), following prior increases in Nov 2025. Wall Street pros: Strong earnings momentum and growth, constructive stance from major brokers, and implied upside to targets. Wall Street cons: Acknowledged sector-level challenges in P&C (potentially tougher fundamentals), which can cap multiples and make execution/earnings critical. Influential/politician activity: No recent congress trading data available; insider and hedge fund activity shown as Neutral with no significant recent trends.
